First Solar will report financial results for the fourth quarter and full year ended Dec. 31, 2024, after the closing bell on ...

Viking Therapeutics (NASDAQ:VKTX – Get Free Report) is expected to release its earnings data after the market closes on ...

'Mad Money' host Jim Cramer weighs in on stock including: Viking Therapeutics, First Solar, RadNet, and Waste Management.

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

In a report released yesterday, Mayank Mamtani from B.Riley Financial maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), ...

Discover the top-performing biotech stocks in 2024! From oncology to psychedelics some companies showed remarkable results.

ONS-5010 (bevacizumab-vikg) was found to be noninferior to ranibizumab for neovascular age-related macular degeneration at week 12.

Silence pervades the site of Auschwitz-Birkenau today. Sometimes the only sounds are the soft footsteps of visitors, people who come from all over the world to mourn and to learn, and the voices of ...

Blending fantasy and romance is often overdone in the literary world today, but I was pleasantly surprised by the perfect ...

And I predict that 2025 will be another momentous year for Summit. Summit already owned the license to market ivonescimab in ...

Novo Nordisk stock surged Friday after the obesity kingpin reported strong results for its next-generation weight-loss drug, amycretin.

Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...